INDOCO REMEDIES
|
The Current P/E Ratio of INDOCO REMEDIES is -21.70.
| Share Price | ₹273.3 | Nov 03,2025 |
| Market Cap | ₹2,519.4 Cr | |
| Earnings-TTM | ₹-116.1 Cr | TTM-Consolidated Results |
| Price/Earnings | -21.70x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of INDOCO REMEDIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,519.4 Cr] as on Nov 03,2025
(/) Earnings [ ₹-116.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -21.70x ]
Thus, for INDOCO REMEDIES , the investors are currently willing to pay -21.70 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INDOCO REMEDIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of INDOCO REMEDIES over the last five years.
Historical PE (Price/Earnings) ratio chart of INDOCO REMEDIES
PE Ratio Performance Analysis for INDOCO REMEDIES
- INDOCO REMEDIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 20.57x.
- INDOCO REMEDIES 's operated at median p/e ratio of 22.42x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDOCO REMEDIES 's p/e ratio peaked in Mar2024 at 30.76x.
- INDOCO REMEDIES 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does INDOCO REMEDIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| INDOCO REMEDIES | -116.10 | -21.70 | 2,519.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 39.34 | 409,626.0 |
| DIVIS LABORATORIES LTD | 2,306.00 | 78.35 | 180,669.0 |
| CIPLA LTD | 5,453.86 | 22.39 | 122,103.0 |
| TORRENT PHARMACEUTICALS LTD | 2,002.00 | 61.34 | 122,793.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 17.45 | 99,857.4 |
| MANKIND PHARMA LTD | 1,905.51 | 52.03 | 99,138.4 |
| ZYDUS LIFESCIENCES LTD | 4,637.80 | 21.28 | 98,686.4 |
| LUPIN LTD | 3,722.18 | 24.37 | 90,706.1 |
| AUROBINDO PHARMA LTD | 3,417.93 | 19.68 | 67,259.7 |
| ABBOTT INDIA LTD | 1,452.29 | 42.55 | 61,800.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INDOCO REMEDIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -21.70x |
| Max industry PE | 78.35x |
| Median industry PE | 24.37x |
| Average industry PE | 32.46x |
You may also like the below Video Courses